A positive correlation between FOXC1 expression and lysyl oxidase (LOX) expression was established in NSCLC patient samples wherein FOXC1 activated LOX transcription to drive cancer progression through the FOXC1-LOX axis (57). This evidence concerns the gene FOXC1 and cancer.